Functional foods as potential therapeutic options for metabolic syndrome
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Summary: Obesity as part of metabolic syndrome is a major lifestyle disorder throughout the world. Current drug treatments for obesity produce small and usually unsustainable decreases in body weight with the risk of major adverse effects. Surgery has been the only treatment producing successful long‐term weight loss. As a different but complementary approach, lifestyle modification including the use of functional foods could produce a reliable decrease in obesity with decreased comorbidities. Functional foods may include fruits such as berries, vegetables, fibre‐enriched grains and beverages such as tea and coffee. Although health improvements continue to be reported for these functional foods in rodent studies, further evidence showing the translation of these results into humans is required. Thus, the concept that these fruits and vegetables will act as functional foods in humans to reduce obesity and thereby improve health remains intuitive and possible rather than proven.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dose translation from animal to human studies revisited.
Reagan‐Shaw, S., Nihal, M., & Ahmad, N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9574lsf · Cited by 6,524 · cited 1×
“Have the human trials tested the interventions for long enough to be effective? Have the animal trials tested the interventions for long enough to show sustained loss of body weight despite an obesogenic diet? The dose of the intervention from animal studies should be appropriately translated to human doses using meta…”
BackgroundNonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Inflammatory Mechanisms in Obesity
Gregor, M. F., & Hotamisligil, G. S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101322 · Cited by 3,754 · cited 1×
“and maintained by the release of adipokines from adipose tissue (4,5).”
BackgroundDietary Intake and Bioavailability of Polyphenols
Scalbert, A., & Williamson, G. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.8.2073s · Cited by 3,658 · cited 1×
“2), found in onions, apples and tea in high concentrations (90,91), have shown positive responses in animal models of human diseases such as hypertension, hyperlipi-”
BackgroundDecreased bioavailability of vitamin D in obesity
Wortsman, J., Matsuoka, L. Y., Chen, T. C., Lu, Z., & Holick, M. F. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.3.690 · Cited by 3,204 · cited 1×
“However, there is some evidence that obese subjects have lower production of vitamin D3 upon exposure to UV radiation (293).”
BackgroundOrigins and evolution of the Western diet: health implications for the 21st century1,2
Cordain, L., Eaton, S. B., Sebastian, A., Mann, N., Lindeberg, S., Watkins, B. A., O’Keefe, J. H., & Brand-Miller, J. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn.81.2.341 · Cited by 2,397
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
Fabbrini, E., Sullivan, S., & Klein, S. (2010) · Hepatology · doi:10.1002/hep.23280 · Cited by 2,100
Trans fatty acids and cardiovascular disease
Mozaffarian, D., Katan, M. B., Ascherio, A., Stampfer, M. J., & Willett, W. C. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054035 · Cited by 1,752
Timmers, S., Konings, E., Bilet, L., Houtkooper, R. H., van de Weijer, T., Goossens, G. H., Hoeks, J., van der Krieken, S., Ryu, D., Kersten, S., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.002 · Cited by 1,320
Oxidative stress in obesity: A critical component in human diseases
Marseglia, L., Manti, S., D’Angelo, G., Nicotera, A., Parisi, E., Di Rosa, G., Gitto, E., & Arrigo, T. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms16010378 · Cited by 933 · cited 1×
“and maintained by the release of adipokines from adipose tissue (4,5).”
BackgroundMeta-Analysis: Pharmacologic Treatment of Obesity
Li, Z., Maglione, M., Tu, W., Mojica, W., Arterburn, D., Shugarman, L. R., Hilton, L., Suttorp, M., Solomon, V., Shekelle, P. G., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-7-200504050-00012 · Cited by 774
Melanoidins produced by the Maillard reaction: Structure and biological activity
Wang, H.-Y., Qian, H., & Yao, W.-R. (2011) · Food Chemistry · doi:10.1016/j.foodchem.2011.03.075 · Cited by 719
Defining high-fat-diet rat models: Metabolic and molecular effects of different fat types
Buettner, R., Parhofer, K. G., Woenckhaus, M., Wrede, C. E., Kunz-Schughart, L. A., Schölmerich, J., & Bollheimer, L. C. (2006) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01909 · Cited by 704
Interactions Between Gut Microbiota and Host Metabolism Predisposing to Obesity and Diabetes
Musso, G., Gambino, R., & Cassader, M. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-012510-175505 · Cited by 598
The medical complications of obesity
Malnick, S. D. H. (2006) · QJM · doi:10.1093/qjmed/hcl085 · Cited by 579 · cited 1×
“In addition to heart and liver diseases, obesity increases the risk of cerebrovascular disease, pulmonary abnormalities, gastrointestinal abnormalities, reproductive disease, psychosocial complications, osteoarthritis and some cancers (13,14).”
BackgroundMindfulness‐based interventions for obesity‐related eating behaviours: a literature review
O'Reilly, G. A., Cook, L., Spruijt‐Metz, D., & Black, D. S. (2014) · Obesity Reviews · doi:10.1111/obr.12156 · Cited by 547 · cited 1×
“The efficacy of mindfulness practices for obesity-related eating behaviours has been reviewed, but one limitation was that few studies propose a theoretical basis for their interventions (60).”
BackgroundLópez-Miranda, J., Pérez-Jiménez, F., Ros, E., De Caterina, R., Badimón, L., Covas, M. I., Escrich, E., Ordovás, J. M., Soriguer, F., Abiá, R., et al. (2010) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.12.007 · Cited by 520
The chemistry and biotransformation of tea constituents
Sang, S., Lambert, J. D., Ho, C.-T., & Yang, C. S. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.02.007 · Cited by 492
Bjermo, H., Iggman, D., Kullberg, J., Dahlman, I., Johansson, L., Persson, L., Berglund, J., Pulkki, K., Basu, S., Uusitupa, M., et al. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.030114 · Cited by 490 · cited 1×
“In obese subjects, 10 weeks of LA-rich diet did not change body weight (265).”
BackgroundNutritional and medical importance of gamma-linolenic acid
Horrobin, D. F. (1992) · Progress in Lipid Research · doi:10.1016/0163-7827(92)90008-7 · Cited by 488 · cited 1×
“The action of Δ(6)-desaturase and elongation enzyme on LA produces pro-inflammatory arachidonic acid (259) with dihomo-γ-linolenic acid as an important intermediate (260).”
BackgroundHigh-Dose Resveratrol Supplementation in Obese Men
Poulsen, M. M., Vestergaard, P. F., Clasen, B. F., Radko, Y., Christensen, L. P., Stødkilde-Jørgensen, H., Møller, N., Jessen, N., Pedersen, S. B., & Jørgensen, J. O. L. (2013) · Diabetes · doi:10.2337/db12-0975 · Cited by 455
Qin, Y., Xia, M., Ma, J., Hao, Y., Liu, J., Mou, H., Cao, L., & Ling, W. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27814 · Cited by 443 · cited 1×
“Although anthocyanins were able to improve endothelial-dependent vasodilatation, reduce LDL-c and increase HDL-c, there was no change in the body weight or BMI of overweight subjects (82,83).”
Backgroundde Wit, N., Derrien, M., Bosch-Vermeulen, H., Oosterink, E., Keshtkar, S., Duval, C., de Vogel-van den Bosch, J., Kleerebezem, M., Müller, M., & van der Meer, R. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00488.2011 · Cited by 428 · cited 1×
“Studies in rodents suggest that SFA stimulates obesity by altering the gut microbiota (increased Firmicutes-toBacteroidetes ratio) and inducing a pro-inflammatory state (200,201).”
BackgroundQiao, Y., Sun, J., Xia, S., Tang, X., Shi, Y., & Le, G. (2014) · Food & Function · doi:10.1039/c3fo60630a · Cited by 367 · cited 1×
“Secondly, resveratrol (200 mg kg−1 d−1 for 12 weeks)-induced body and visceral adipose weight loss in mice was associated with improved gut microbiota dysbiosis induced by highfat diet, including an increased Bacteroidetes-to-Firmicutes ratio, inhibition of the growth of Enterococcus faecalis, increased growth of Lact…”
BackgroundMozaffarian, D., Cao, H., King, I. B., Lemaitre, R. N., Song, X., Siscovick, D. S., & Hotamisligil, G. S. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-12-201012210-00005 · Cited by 363
Coffee Melanoidins: Structures, Mechanisms of Formation and Potential Health Impacts
Moreira, A. S. P., Nunes, F. M., Domingues, M. R., & Coimbra, M. A. (2012) · Food & Function · doi:10.1039/c2fo30048f · Cited by 346
Woodman, R. J., Mori, T. A., Burke, V., Puddey, I. B., Watts, G. F., & Beilin, L. J. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.5.1007 · Cited by 338
Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats
An, H. M., Park, S. Y., Lee, D. K., Kim, J. R., Cha, M. K., Lee, S. W., Lim, H. T., Kim, K. J., & Ha, N. J. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-116 · Cited by 320
Vitamin status in morbidly obese patients: a cross-sectional study
Aasheim, E. T., Hofsø, D., Hjelmesæth, J., Birkeland, K. I., & Bøhmer, T. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.2.362 · Cited by 316 · cited 1×
“Vitamin B6, vitamin C and vitamin D were also reduced in obese subjects (301).”
BackgroundGlade, M. J. (2010) · Nutrition · doi:10.1016/j.nut.2010.08.004 · Cited by 306
Grimsgaard, S., Bonaa, K., Hansen, J., & Nordøy, A. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/66.3.649 · Cited by 300
Pharmacokinetics and metabolism of natural methylxanthines in animal and man
Arnaud, M. J. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-13443-2_3 · Cited by 259
The current trends and future perspectives of prebiotics research: A review
Patel, S., & Goyal, A. (2012) · 3 Biotech · doi:10.1007/s13205-012-0044-x · Cited by 256
Central efferent pathways for cold-defensive and febrile shivering
Nakamura, K., & Morrison, S. F. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.210047 · Cited by 238
Worldwide consumption of functional foods: A systematic review
Ozen, A. E., Pons, A., & Tur, J. A. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2012.00492.x · Cited by 229
Resveratrol: Anti-Obesity Mechanisms of Action
Aguirre, L., Fernández-Quintela, A., Arias, N., & Portillo, M. (2014) · Molecules · doi:10.3390/molecules191118632 · Cited by 205 · cited 1×
“At the cellular level, resveratrol induces physiological and molecular changes such as suppression of de novo lipogenesis and adipogenesis as well as increased adipocyte apoptosis, lipolysis, fat oxidation and thermogenesis to promote fat loss (143).”
BackgroundLee, K., Paek, K., Lee, H. Y., Park, J. H., & Lee, Y. (2007) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2007.03336.x · Cited by 175
Assunção, M. L., Ferreira, H. S., dos Santos, A. F., Cabral, C. R., & Florêncio, T. M. M. T. (2009) · Lipids · doi:10.1007/s11745-009-3306-6 · Cited by 174
Quercetin Protects against Obesity-Induced Skeletal Muscle Inflammation and Atrophy
Le, N. H., Kim, C.-S., Park, T., Park, J. H. Y., Sung, M.-K., Lee, D. G., Hong, S.-M., Choe, S.-Y., Goto, T., Kawada, T., et al. (2014) · Mediators of Inflammation · doi:10.1155/2014/834294 · Cited by 167
Parkinson, L., & Keast, R. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150712323 · Cited by 156
Schwingshackl, L., Strasser, B., & Hoffmann, G. (2011) · Annals of Nutrition and Metabolism · doi:10.1159/000334071 · Cited by 150
Konings, E., Timmers, S., Boekschoten, M. V., Goossens, G. H., Jocken, J. W., Afman, L. A., Müller, M., Schrauwen, P., Mariman, E. C., & Blaak, E. E. (2014) · International Journal of Obesity · doi:10.1038/ijo.2013.155 · Cited by 143
Kang, J.-H., Yun, S.-I., & Park, H.-O. (2010) · The Journal of Microbiology · doi:10.1007/s12275-010-0363-8 · Cited by 135
Resveratrol and obesity: can resveratrol relieve metabolic disturbances?
de Ligt, M., Timmers, S., & Schrauwen, P. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.11.012 · Cited by 135 · cited 1×
“Thirdly, in rats fed an obesogenic diet, resveratrol supplementation (30 mg kg−1 d−1 for 6 weeks) increased the expression of genes involved in cellular energy homeostasis and mitochondrial biogenesis in the interscapular brown adipose tissue such as mitochondrial transcription factor A, mitochondrial protein cytochro…”
BackgroundMedical treatment of obesity: The past, the present and the future
Bray, G. A. (2014) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2014.07.015 · Cited by 109
Henagan, T. M., Cefalu, W. T., Ribnicky, D. M., Noland, R. C., Dunville, K., Campbell, W. W., Stewart, L. K., Forney, L. A., Gettys, T. W., Chang, J. S., et al. (2015) · Genes & Nutrition · doi:10.1007/s12263-014-0451-1 · Cited by 102
Gómez-Zorita, S., Fernández-Quintela, A., Lasa, A., Hijona, E., Bujanda, L., & Portillo, M. P. (2013) · Nutrition · doi:10.1016/j.nut.2013.04.014 · Cited by 79 · cited 1×
“protein and leptin) in obese rodents (156,157).”
Therapies for inter-relating diabetes and obesity – GLP-1 and obesity
Iepsen, E. W., Torekov, S. S., & Holst, J. J. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.965678 · Cited by 43 · cited 1×
“Since all food taken by mouth must pass through the gastrointestinal tract for absorption or excretion, the energy intake can be modified by the actions of hormones produced by the cells lining the gastrointestinal tract, including the incretin hormone glucagon-like peptide-1, and so glucagon-like peptide-1 may be inv…”
BackgroundEffect of dietary resveratrol on the metabolic profile of nutrients in obese OLETF rats
Nagao, K., Jinnouchi, T., Kai, S., & Yanagita, T. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-8 · Cited by 29 · cited 1×
“5% for 4 weeks) (150), fructose-fed rats (10 mg kg−1 d−1 for 8 weeks) (151) and Zucker fatty rats (15 or 45 mg kg−1 d−1 for 6 weeks) (152).”
Cited by
Ramos-Romero, S., Torrella, J. R., Pagès, T., Viscor, G., & Torres, J. L. (2021) · Nutrients · doi:10.3390/nu13020563 · Cited by 134
Zarezadeh, M., Faghfouri, A. H., Radkhah, N., Foroumandi, E., Khorshidi, M., Rasouli, A., Zarei, M., Mohammadzadeh Honarvar, N., Hazhir Karzar, N., & Ebrahimi Mamaghani, M. (2021) · Phytotherapy Research · doi:10.1002/ptr.6834 · Cited by 46
Metadata
- Authors
- Brown, L., Poudyal, H., & Panchal, S. K.
- Venue
- Obesity Reviews
- Publisher
- Wiley
- Published
- 2015-09-08
- Volume
- 16
- Issue
- 11
- Pages
- 914-941
- ISSN
- 1467-7881 (ISSN-L)
- 1467-789X
- OpenAlex
- W1604245576
- Cited by
- 158
- References
- 49
- FWCI
- 8.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.